ribavirin has been researched along with Disbacteriosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bose, D; Chatterjee, S; Holland, LA; Horner, RD; Janulewicz Lloyd, P; Kimono, D; Klimas, N; Lim, ES; Maqsood, R; Mondal, A; Seth, RK; Sullivan, K | 1 |
| Bajaj, JS; Betrapally, NS; Daita, K; Fuchs, M; Ganapathy, D; Gillevet, PM; Heuman, DM; Hylemon, PB; Nixon, DE; Sikaroodi, M; Sterling, RK; White, MB | 1 |
2 other study(ies) available for ribavirin and Disbacteriosis
| Article | Year |
|---|---|
Gut DNA Virome Diversity and Its Association with Host Bacteria Regulate Inflammatory Phenotype and Neuronal Immunotoxicity in Experimental Gulf War Illness.
Topics: Animals; Antiviral Agents; Bacteria; Cytokines; Disease Models, Animal; DNA; Dysbiosis; Gastrointestinal Microbiome; Immunity, Innate; Inflammation; Male; Mice; Mice, Inbred C57BL; Neurons; Permethrin; Persian Gulf Syndrome; Phenotype; Pyridostigmine Bromide; Ribavirin; Viruses | 2019 |
HCV eradication does not impact gut dysbiosis or systemic inflammation in cirrhotic patients.
Topics: Adult; Aged; Antiviral Agents; Case-Control Studies; Dysbiosis; Female; Hepacivirus; Hepatitis C; Humans; Inflammation; Interferons; Liver Cirrhosis; Male; Microbiota; Middle Aged; Outpatients; Ribavirin | 2016 |